ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

NCAB Approves New Pancreatic Cancer Project, Hears Favorable Reports On Organ site Programs

November 29, 1974

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981